Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry.

Front Immunol · 2012 · PMC3556568 · PMID 23372567

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

For each virus studied, we identified at least 61% potential CTL donors with highly significant differences in frequencies of T cells against each of the six viral antigens tested: pp65 and IE-1 (CMV), BZLF1, LMP2A, and EBNA1 (EBV), and hexon (ADV).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.